Global Markets and Technologies for Advanced Drug Delivery Systems - Focus on Routes of Administration
| 出版 | BCC Research |
| 出版年月 | 2025年12月 |
| ページ数 | 339 |
| 価格 | 記載以外のライセンスについてはお問合せください |
| シングルユーザ | USD 4,650.00 |
| 企業ライセンス | USD 8,035.00 |
| 種別 | 英文調査報告書 |
| 商品番号 | SMR-11431 |
Report Highlights
The global market for advanced drug delivery systems (ADDS) is estimated to grow from $299.6 billion in 2025 and projected to reach $487.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Report Includes
- 170 data tables and 79 additional tables
- Overview and an analysis of the global markets and technologies for advanced drug delivery systems (ADDS) with a focus on the routes of administration (RoA)
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the advanced drug delivery systems, accompanied by a market share analysis by route of administration, technology, application, vehicle/carrier and region
- Analysis of current and future demand in the global advanced drug delivery systems market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
- Market share analysis of the key market participants in the advanced drug delivery systems market, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of the leading global players, including AbbVie Inc., GSK plc, AstraZeneca, Novartis AG, Roche and Johnson & Johnson Services, Inc.
Report Scope
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems’ current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
The report aims to:
- Analyze types of ADDS.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness and industry structure.
- Identify potential long-term impacts on the advanced drug delivery systems market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||||
| Base year market size | $275.2 Billion | ||||||||||||||||||
| Market size forecast | $487.4 Billion | ||||||||||||||||||
| Growth rate | CAGR of 10.2% from 2025 to 2030 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | By Route of Administration (RoA), Technology, Application, Drug Vehicle/Carrier, and Region | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America | ||||||||||||||||||
| Countries covered | The U.S., Canada, Mexico, Brazil, Argentina, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, India, The Middle East and Africa | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
||||||||||||||||||
Table of Contents
Chapter- 1: Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter- 2: Market Overview
Overview
Macroeconomic Factors Analysis
Porter’s Five Forces Analysis
Chapter- 3: Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Chapter- 4: Regulatory Landscape
Overview
Chapter- 5: Emerging Technologies and Pipeline Analysis
Overview
Clinical Trial Analysis
Patent Analysis
Chapter- 6: Market Segmentation Analysis
Segmentation Breakdown
Global Market for Advanced Drug Delivery Systems, by Route of Administration
Global Market for Advanced Drug Delivery Systems, by Technology
Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier
Global Market for Advanced Drug Delivery Systems, by Application
Geographic Breakdown
Global Market for Advanced Drug Delivery Systems, by Region
Chapter- 7: Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter- 8: Sustainability in the Advanced Drug Delivery Systems Market: An ESG Perspective
Introduction to ESG
Sustainability in the Advanced Drug Delivery Systems Market
ESG Perspective
ESG Risk Ratings
Conclusion
Chapter- 9: Appendix
Methodology
Abbreviations
Sources
Company Profiles
Emerging Companies in the Advanced Drug Delivery Systems Market